Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Longitudinal immune dynamics associated with chronic lymphocytic leukemia development in mice with 13q14 deletion and modulation by early BTK inhibition

Patricia Fernández-Guzmán, Iñaki Salvador Corres, Hristo Iliev Iliev, Gemma Pujadas Rovira, Víctor Navarro Garces, Anna Aguilera Romero, Josep Castellvi, Daniel Medina-Gil, Maite Erguin, Sofia Mallorquí-Alcalá, Angel Serna, Pau Abrisqueta, Francesc Bosch Albareda, Marta Crespo

Blood (2025) 146 (Supplement 1): 5656.

https://doi.org/10.1182/blood-2025-5656

Published: 2025

Journal Articles

Dissecting the heterogeneity of IGHV-mutated CLL: An eric study.

Thomas Chatzikonstantinou, Andreas Agathangelidis, Persefoni Talimtzi, Stamatia Laidou, Eva Minga, Athanasios Roussos, Maria Angelopoulou, Miguel Arguello De Tomas, Darko Antic, Fanny Baran-Marszak, Csaba Bödör, Francesc Bosch Albareda, Mark Catherwood, Sophia Chatzileontiadou, Caterina Chessa, Marta Coscia, Marta Crespo, Antonio Cuneo, Zadie Davis, Maria Dimou, Michael Doubek, Maria Efstathopoulou, Blanca Espinet, Gianluca Gaidano, Ritu Gupta, Eleftheria Hatzimichael, Yair Herishanu, Thalia Karamanli, Eliana Konstantinou, Ioannis Kotsianidis, Andreas Epameinondas Koumpis, Tamas Laszlo, Vincent Levy, Alexandros Machairas, Francesca Martini, Riccardo Moia, Samir Mouhssine, Ana Muntanola Prat, Roberta Murru, Eugenia Mpalaoura, Gerassimos Pangalis, Maria Papaioannou, Sarka Pavlova, Karla Plevova, Sarka Pospisilova, Anna Puiggros, Lata Rani, Gian Matteo Rigolin, Ilaria Romano, Davide Rossi, Angel Serna, Martin Simkovic, Lukas Smolej, Niki Stavrogianni, Kristina Tomic Vujovic, Livio Trentin, Theodoros Vassilakopoulos, Andrea Visentin, Candida Vitale, George Vrachiolias, Lydia Scarfo, Anastasia Chatzidimitriou, Paolo Ghia, Kostas Stamatopoulos

Blood (2025) 146 (Supplement 1): 2120.

https://doi.org/10.1182/blood-2025-2120

Published: 2025

Journal Articles

ST2 as a biomarker of cytokine release syndrome following CD19-targeted chimeric antigen receptor T-cell therapy

Guillermo Orti, Cecilia Carpio, Gloria Iacoboni, Lorenzo Carita, Samantha Feijoo, Corrado Benevolo Savelli, Mario Sánchez-Salinas, Alfredo Rivas-Delgado, Víctor Navarro Garces, Sergi Cantenys-Molina, Monica Martinez, Miguel Gonzalez, Marta Crespo, Pau Abrisqueta, Francesc Bosch Albareda, Pere Barba

Blood (2025) 146 (Supplement 1): 2365.

https://doi.org/10.1182/blood-2025-2365

Published: 2025

Journal Articles

Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.

Thomas Chatzikonstantinou, Sevasti Konstantinou, Persefoni Talimtzi, Eva Minga, Maria Angelopoulou, Francesco Angotzi, Marcello Bradaschia, Sophia Chatzileontiadou, Caterina Chessa, Marta Crespo, Maria Dimou, Alessandro Gozzetti, Ritu Gupta, Eliana Konstantinou, Andreas Epameinondas Koumpis, Alexandros Machairas, Francesca Martini, Riccardo Moia, Samir Mouhssine, Roberta Murru, Leila Perobelli, Lata Rani, Ilaria Romano, Gian Matteo Rigolin, Angel Serna, Andrea Visentin, Candida Vitale, George Vrachiolias, Celso Arrais-Rodrigues, Rodrigo Santucci da Silva, Carlos Chiattone, Francesc Bosch Albareda, Anastasia Chatzidimitriou, Marta Coscia, Antonio Cuneo, Gianluca Gaidano, Eleftheria Hatzimichael, Yair Herishanu, Ioannis Kotsianidis, Panagiotis Panagiotidis, Maria Papaioannou, Davide Rossi, Niki Stavrogianni, Livio Trentin, Theodoros Vassilakopoulos, Kostas Stamatopoulos, Paolo Ghia, Lydia Scarfo

Blood (2025) 146 (Supplement 1): 5665.

https://doi.org/10.1182/blood-2025-5665

Published: 2025

Journal Articles

Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.

Thomas Chatzikonstantinou, Persefoni Talimtzi, Eva Minga, Maria Angelopoulou, Miguel Arguello De Tomas, Darko Antic, Celso Arrais-Rodrigues, Francesc Bosch Albareda, Marcello Bradaschia, Alessandro Cellini, Mark Catherwood, Sophia Chatzileontiadou, Caterina Chessa, Carlos Chiattone, Rosa Collado, Marta Coscia, Marta Crespo, Antonio Cuneo, Zadie Davis, Maria Dimou, Michael Doubek, Maria Efstathopoulou, Blanca Espinet, Gianluca Gaidano, Rocio Garcia-Serra, Alessandro Gozzetti, Ritu Gupta, Eleftheria Hatzimichael, Yair Herishanu, Ozren Jaksic, Maria Kislova, Eliana Konstantinou, Sevasti Konstantinou, Maya Koren Michowitz, Ioannis Kotsianidis, Andreas Epameinondas Koumpis, Luca Laurenti, Alexandros Machairas, Francesca Martini, Riccardo Moia, Samir Mouhssine, Ana Muntanola Prat, Roberta Murru, Rocio Nieves Salgado Sanchez, Gerassimos Pangalis, Maria Papaioannou, Sarka Pavlova, Leila Perobelli, Sarka Pospisilova, Anna Puiggros, Claus Rainer, Sergio Ramos, Lata Rani, Gian Matteo Rigolin, Ilaria Romano, Davide Rossi, Rodrigo Santucci, Angel Serna, Marina Siakantaris, Talita Silveira, Paolo Sportoletti, Niki Stavrogianni, Annamaria Tomasso, Kristina Tomic Vujovic, Livio Trentin, Theodoros Vassilakopoulos, Andrea Visentin, Candida Vitale, George Vrachiolias, Munci Yagci, Seyma Yildiz, Anastasia Chatzidimitriou, Kostas Stamatopoulos, Paolo Ghia, Lydia Scarfo

Blood (2025) 146 (Supplement 1): 5664.

https://doi.org/10.1182/blood-2025-5664

Published: 2025

Journal Articles

Impact of extranodal involvement on bispecific antibody (BsAb) outcomes in patients with large B-cell lymphoma (LBCL)

Blood (2025) 146 (Supplement 1): 1962.

https://doi.org/10.1182/blood-2025-1962

Published: 2025

Journal Articles

Immune Crosstalk Profiling of Non-Hodgkin Lymphoma (NHL) Tumor Immune Microenvironment Identifies Two Clusters Based on T Cell Exhaustion, Correlating with Different Clinical Outcomes

Daniel Medina, Laura Palomo, Víctor Navarro, Cristina García, Juan Camilo Nieto, Júlia Carabia, Carlota Pagès Geli, Pamela Acha, Gemma Pujadas, Carlos Palacio, Laura Gallur, Josep Castellvi, Pau Abrisqueta, Francesc Bosch, Marta Crespo

Blood (2024) 144 (Supplement 1): 6251.

https://doi.org/10.1182/blood-2024-205108

Published: 2024

Journal Articles

Ibromics: A Real-World Study of Clinical and Biological Parameters in Patients with Chronic Lymphocytic Leukemia (CLL) Treated in First Line with Single Agent Ibrutinib

Cecilia Muñoz-Calleja, José Ángel Hernández-Rivas, Francesc Bosch, Laura Palomo, Adrian Mosquera Orgueira, Angel Ramirez, Ruben Fernandez Alvarez, Ana C Oliveira, Paula Amat Martinez, Alicia Serrano, Aránzazu García-Grande, Ana Yeguas, Marta Crespo, Miguel Alcoceba, Blanca Ferrer Lores, José Antonio Garcia Vela, Luis Espinosa-Hevia, Celia Bolumburu, Miguel Villanueva Forero

Blood (2024) 144 (Supplement 1): 6769.

https://doi.org/10.1182/blood-2024-199097

Published: 2024

Journal Articles

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Blood (2023) 142 (Supplement 1): 3927.

https://doi.org/10.1182/blood-2023-191146

Published: 2023

Journal Articles

Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target

Daniel Medina, Laura Palomo, Víctor Navarro, Oriol Castells, Belén Sánchez, Pau Marc Muñoz Torres, Carlota Pagès Geli, Cristina Hernández, Gemma Pujadas, Alba Cabirta Touzón, Christelle Ferrà, Miguel Alcoceba, María José Terol, Rafael Andreu, Francesc Bosch, Pau Abrisqueta, Marta Crespo

Blood (2023) 142 (Supplement 1): 3254.

https://doi.org/10.1182/blood-2023-185683

Published: 2023

Journal Articles

Deciphering Transcriptomic and (Epi)Genetic Signatures of Central Nervous System Infiltration in Patients Diagnosed with Diffuse Large B-Cell Lymphoma

Carlota Pages-Geli, Sabela Bobillo, Pau Abrisqueta, Josep Castellvi, Laura Palomo, Damiana Alvarez, Manel Esteller, Francesc Bosch, Marta Crespo

Blood (2023) 142 (Supplement 1): 1618.

https://doi.org/10.1182/blood-2023-174653

Published: 2023

Journal Articles

Macrophages Play a Key Role in Controlling Tumor Growth and Response to Immunotherapy in Primary Central Nervous System Lymphoma

Carlota Pages-Geli, Daniel Medina, Cristina Hernandez, Patricia Fernandez, Gemma Pujadas, Francesc Bosch, Marta Crespo

Blood (2023) 142 (Supplement 1): 1642.

https://doi.org/10.1182/blood-2023-180719

Published: 2023

Journal Articles

Resistance Mechanisms Impacting Bispecific Antibody (BsAbs) and Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcomes in Large B Cell Lymphoma (LBCL) Patients

Blood (2023) 142 (Supplement 1): 1635.

https://doi.org/10.1182/blood-2023-186072

Published: 2023

Journal Articles

Clinical Impact of Sars-Cov-2 Vaccination in COVID-19 Outcomes in Patients Diagnosed with Hematologic Malignancies: Real-World Evidence of Two Years of Pandemic

Blood (2022) 140 (Supplement 1): 2628–2630.

https://doi.org/10.1182/blood-2022-169321

Published: 2022

Journal Articles

Epidemiological Characterization and Determination of TP53 and IGHV Mutational Status of a Large Series of Previously-Untreated Chronic Lymphocytic Leukemia (CLL) Patients in Spain: The Epicll Study

María José Terol, Alicia Serrano, Blanca Ferrer Lores, Francesc Bosch, Marcos Gonzalez Diaz, Marta Crespo, Miguel Alcoceba, Azahara Fuentes, Javier F Chaves, Lucia Esteve, Cristina Loriente, Miguel Villanueva

Blood (2021) 138 (Supplement 1): 1564.

https://doi.org/10.1182/blood-2021-150278

Published: 2021

Journal Articles

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

Blood (2021) 137 (16): 2267–2271.

https://doi.org/10.1182/blood.2020008609

Published: 2021

Includes: Supplemental data

Journal Articles

Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab

Juan C Nieto, PhD, Elisa Roldan, MD, Isabel Jiménez, MSc, Laura Fox, Júlia Carabia, PhD, Guillermo Orti, Lluis Puigdefàbregas, Laura Gallur, Gloria Iacoboni, MD, Priyanka Raheja, Ana Perez, Olga Salamero, MD, Carlos Palacio, David Valcarcel, MD, Marta Crespo, PhD, Francesc Bosch, MD, Pere Barba, MD

Blood (2018) 132 (Supplement 1): 3402.

https://doi.org/10.1182/blood-2018-99-114887

Published: 2018

Journal Articles

Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells

Isabel Jiménez, MSc, Sabela Bobillo, MD, Pau Abrisqueta, MD PhD, Bárbara Tazón, PhD, Carles Palacio, MD, Juan C Nieto, PhD, Júlia Carabia, MSc, Maria Jose Terol, MD PhD, Jose Garcia-Marco, MD PhD, Joan Boix, BSc, Magdalena Munuera, BSc, Lluis Puigdefàbregas, Elisa Roldán, Marta Crespo, PhD, Francesc Bosch

Blood (2017) 130 (Supplement 1): 1713.

https://doi.org/10.1182/blood.V130.Suppl_1.1713.1713

Published: 2017

Journal Articles

Xpo-1 Inhibition Synergizes with BCR Inhibition, Blocks Tumor Growth and Tumor-Associated Macrophages Infiltration and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Marta Crespo, PhD, Júlia Carabia, MSc, Isabel Jiménez, MSc, Sabela Bobillo, MD, Pau Abrisqueta, MD PhD, Carles Palacio, MD, Juan C Nieto, PhD, Joan Boix, BSc, Cecilia Carpio, MD, Josep Castellvi, Joan Seoane, Francesc Bosch

Blood (2017) 130 (Supplement 1): 2808.

https://doi.org/10.1182/blood.V130.Suppl_1.2808.2808

Published: 2017

Journal Articles

XPO1 Inhibition By Selinexor Synergizes with BCR Inhibition, Blocks Tumor Growth and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Marta Crespo, Julia Carabia, Isabel Jiménez, Sabela Bobillo, Pau Abrisqueta, Carles Palacio, Cecilia Carpio, MD, Josep Castellvi, Noelia Purroy, Joan Seoane, Francesc Bosch, MD PhD

Blood (2016) 128 (22): 463.

https://doi.org/10.1182/blood.V128.22.463.463

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Longitudinal immune dynamics associated with chronic lymphocytic leukemia development in mice with 13q14 deletion and modulation by early BTK inhibition

Dissecting the heterogeneity of IGHV-mutated CLL: An eric study.

ST2 as a biomarker of cytokine release syndrome following CD19-targeted chimeric antigen receptor T-cell therapy

Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.

Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.

Impact of extranodal involvement on bispecific antibody (BsAb) outcomes in patients with large B-cell lymphoma (LBCL)

Immune Crosstalk Profiling of Non-Hodgkin Lymphoma (NHL) Tumor Immune Microenvironment Identifies Two Clusters Based on T Cell Exhaustion, Correlating with Different Clinical Outcomes

Ibromics: A Real-World Study of Clinical and Biological Parameters in Patients with Chronic Lymphocytic Leukemia (CLL) Treated in First Line with Single Agent Ibrutinib

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target

Deciphering Transcriptomic and (Epi)Genetic Signatures of Central Nervous System Infiltration in Patients Diagnosed with Diffuse Large B-Cell Lymphoma

Macrophages Play a Key Role in Controlling Tumor Growth and Response to Immunotherapy in Primary Central Nervous System Lymphoma

Resistance Mechanisms Impacting Bispecific Antibody (BsAbs) and Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcomes in Large B Cell Lymphoma (LBCL) Patients

Clinical Impact of Sars-Cov-2 Vaccination in COVID-19 Outcomes in Patients Diagnosed with Hematologic Malignancies: Real-World Evidence of Two Years of Pandemic

Epidemiological Characterization and Determination of TP53 and IGHV Mutational Status of a Large Series of Previously-Untreated Chronic Lymphocytic Leukemia (CLL) Patients in Spain: The Epicll Study

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab

Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells

Xpo-1 Inhibition Synergizes with BCR Inhibition, Blocks Tumor Growth and Tumor-Associated Macrophages Infiltration and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

XPO1 Inhibition By Selinexor Synergizes with BCR Inhibition, Blocks Tumor Growth and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only